New Long-Acting shot for HIV in kids shows promise in early trial

NCT ID NCT06749054

First seen Nov 05, 2025 · Last updated May 16, 2026 · Updated 25 times

Summary

This study tests a long-acting HIV medicine called lenacapavir in teens and children (weighing at least 35 kg) who have tried other HIV drugs before. The goal is to see if the drug is safe, tolerable, and works well when combined with other HIV medications. Participants will receive lenacapavir as an injection or pill, and researchers will monitor drug levels and side effects over 26 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV-1 INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Be Part Research Pty (Ltd)

    RECRUITING

    Paarl, 7626, South Africa

  • CRISMO Research Centre

    RECRUITING

    Germiston, 1401, South Africa

  • Clinical Research Institute of South Africa (CRISA)

    RECRUITING

    KwaDukuza, 4449, South Africa

  • Durban International Clinical Research Site, Enhancing Care Foundation

    RECRUITING

    KwaZulu - Natal, 4093, South Africa

  • FAMCRU

    RECRUITING

    Cape Town, 7505, South Africa

  • Grady Health System, Ponce De Leon Center

    RECRUITING

    Atlanta, Georgia, 30308, United States

  • Perinatal HIV Research Unit (PHRU)

    WITHDRAWN

    Soweto, 2013, South Africa

  • Rahima Moosa Mother and Child Hospital

    RECRUITING

    Johannesburg, 2112, South Africa

  • Wits RHI Shandukani Research Centre CRS

    RECRUITING

    Johannesburg, 2038, South Africa

Conditions

Explore the condition pages connected to this study.